Bone Marrow Mononuclear Cells Activate Angiogenesis via Gap Junction-Mediated Cell-Cell Interaction.

Area of Science:

• Regenerative Medicine
• Cell Biology
• Vascular Biology

Background:

• Bone marrow mononuclear cells (BM-MNCs) are utilized in experimental therapies for ischemic diseases.
• Angiogenesis activation is a key mechanism of BM-MNCs, but the precise pathway remains unclear.

Purpose of the Study:

• To elucidate the mechanism by which BM-MNCs activate angiogenesis.
• To investigate the role of direct cell-cell interaction in BM-MNC-mediated angiogenesis.

Main Methods:

• In vitro evaluation of BM-MNC and endothelial cell interaction on VEGF uptake.
• Cerebral ischemia model to assess BM-MNC effects on endothelial cells in ischemic tissue.
• Gap junction blockade to determine its role in cell interaction and substance transfer.

Main Results:

• BM-MNCs increased VEGF uptake in endothelial cells, an effect inhibited by gap junction blockade.
• Low-molecular-weight substances, including glucose, were transferred from BM-MNCs to endothelial cells via gap junctions.
• This transfer led to increased HIF-1α expression and suppressed autophagy in endothelial cells.

Conclusions:

• Cell-cell interaction via gap junctions is crucial for angiogenesis activation in endothelial cells post-ischemia.
• Stem cell-based therapy may involve supplying energy sources, like glucose, to injured cells, representing a novel therapeutic paradigm.